title: Uracil/tegafur plus oral leucovorin does not affect survival rates but may be better tolerated than standard fluorouracil and leucovorin for previously untreated metastatic colorectal cancer.
authors.affiliation: Department of Gastroenterology, University Medical Center Ljubljana, Slovenia. borut.stabuc@kclj.si
authors.forename: Borut
authors.initials: B
authors.lastname: Stabuc